InvestorsHub Logo
Followers 25
Posts 2697
Boards Moderated 2
Alias Born 09/15/2011

Re: None

Thursday, 03/20/2025 10:01:27 AM

Thursday, March 20, 2025 10:01:27 AM

Post# of 235015
·From the FB page:
In my humble opinion something big is coming In cancer.
1. They put together an oncology board out of the blue.
2. The letter started with cancer & ended with “This is no longer a platform drug in search of an indication; we now have compelling data to support a role for leronlimab in solid-tumor oncology & are executing on that vision”.
3 “ leronlimab could play a significant role as a paradigm-shifting therapeutic in oncology”
4 “This is only the beginning of the Company’s 2025 oncology story”
5 “the developments in oncology have set the stage for 2025 to be a benchmark year for CytoDyn”
6 They are excited to share the results but can’t until after the ESMO conference.
7 They set up a new protocol to continue monitoring the survival patients
8 They began 2 preclinical’s in cancer & more importantly added a 3rd to “ further examine the apparent mechanism behind the observed increase in survival as compared to existing treatment paths”
9. Max’s post was all about mTNBC & not his HIV specialty
Buckle up!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News